Nivarox has a total of 2167 patents globally, out of which 1490 have been granted. Of these 2167 patents, more than 78% patents are active. Europe (EPO) is where Nivarox has filed the maximum number of patents, followed by Switzerland and Japan. Parallelly, Europe (EPO) seems to be the main focused R&D centre and also Switzerland is the origin country of Nivarox.
Nivarox was founded in the year 1984. Nivarox-FAR SA, a subsidiary of Swatch Group, is a key player in the Swiss watchmaking industry. It specializes in producing high-precision components like balance springs and escapements, essential for mechanical watches. Known for its innovation and craftsmanship, Nivarox-FAR supports leading luxury watch brands, ensuring superior accuracy and reliability.
Do read about some of the most popular patents of Nivarox which have been covered by us in this article and also you can find Nivarox patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Nivarox patent portfolio.
How many patents does Nivarox have?
Nivarox has a total of 2167 patents globally. These patents belong to 410 unique patent families. Out of 2167 patents, 1707 patents are active.
How Many Patents did Nivarox File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Nivarox Applications Filed | Nivarox Patents Granted |
2024 | 18 | 88 |
2023 | 70 | 106 |
2022 | 80 | 116 |
2021 | 75 | 112 |
2020 | 121 | 143 |
2019 | 146 | 127 |
2018 | 103 | 166 |
2017 | 154 | 169 |
2016 | 247 | 112 |
2015 | 218 | 103 |
2014 | 203 | 88 |
2013 | 176 | 74 |
How many Nivarox patents are Alive/Dead?
How Many Patents did Nivarox File in Different Countries?
Countries in which Nivarox Filed Patents
Country | Patents |
Europe (EPO) | 276 |
Switzerland | 230 |
Japan | 225 |
United States of America | 218 |
China | 214 |
Hong Kong (S.A.R.) | 206 |
India | 190 |
Germany | 172 |
Austria | 147 |
Russia | 115 |
Taiwan | 87 |
Thailand | 9 |
Korea (South) | 7 |
United Kingdom | 5 |
France | 3 |
Singapore | 2 |
Indonesia | 1 |
Where are Research Centres of Nivarox Patents Located?
10 Best Nivarox Patents
EP2060534A1 is the most popular patent in the Nivarox portfolio. It has received 62 citations so far from companies like Rolex, CSEM and ETA SA.
Below is the list of 10 most cited patents of Nivarox:
Publication Number | Citation Count |
EP2060534A1 | 62 |
EP2104008A1 | 38 |
WO2009115463A1 | 34 |
EP2104007A1 | 33 |
WO2007099068A1 | 33 |
US8206029B2 | 32 |
WO2010020515A1 | 29 |
EP2157476A1 | 28 |
EP2182096A1 | 27 |
EP1826634A1 | 27 |
What Percentage of Nivarox US Patent Applications were Granted?
Nivarox (Excluding its subsidiaries) has filed 219 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 185 have been granted leading to a grant rate of 93.43%.
Below are the key stats of Nivarox patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Nivarox?
Law Firm | Total Applications | Success Rate |
Oblon Mcclelland Maier & Neustadt LLP | 175 | 96.16% |
Sughrue Mion Pllc | 39 | 99.11% |
Griffin & Szipl Pc | 2 | 50.00% |
Weil, Gotshal & Manges | 2 | 100.00% |
Davis, Hoxie, Faithfull & Hapgood | 1 | 100.00% |
What are Nivarox key innovation segments?
What Technologies are Covered by Nivarox?
The chart below distributes patents filed by Nivarox in different countries on the basis of the technology protected in patents. It also represents the markets where Nivarox thinks it’s important to protect particular technology inventions.
R&D Focus: How has Nivarox search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Nivarox?